Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00527111 · ClinicalTrials.gov registry record · Phase 2
Pre-op Rectal ChemoRad +/- Cetuximab
A Phase 2 study, sponsored by US Oncology Research.
- Completed
- Registry status
- Phase 2
- Development phase
- 139
- Enrollment target
NCT00527111 is a Phase 2 study that has completed, run by US Oncology Research. The registered enrollment target is 139 participants.
The verdict
NCT00527111, a Phase 2 study, has completed, sponsored by US Oncology Research.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 139 participants
- Enrollment target
Study Summary
The purpose of this research study is to find out what effects (good and bad) cetuximab has on rectal cancer.
Interventions
- DRUG Cetuximab
- DRUG 5-fluorouracil
- RADIATION Pelvic irradiation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 139 participants |
| Start Date | 2007-02 |
| Est. Completion | 2015-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00527111
The ClinicalTrials.gov registry entry for NCT00527111 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 139 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Oncology Research, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Cetuximab is the first listed.
NCT00527111 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00527111 about?
NCT00527111 is a clinical study titled "Pre-op Rectal ChemoRad +/- Cetuximab". The purpose of this research study is to find out what effects (good and bad) cetuximab has on rectal cancer.
What is the current status of trial NCT00527111?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 139 participants. The study started on 2007-02. Estimated completion is 2015-01.
What interventions are being tested in trial NCT00527111?
The interventions under investigation include: Cetuximab (DRUG), 5-fluorouracil (DRUG), Pelvic irradiation (RADIATION).
Who is sponsoring clinical trial NCT00527111?
This trial is sponsored by US Oncology Research, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.